Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M300048-MCP200 on May 29, 2003.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M300048-MCP200v1
2/5/346    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krokhin, O.
Right arrow Articles by Standing, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krokhin, O.
Right arrow Articles by Standing, K. G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 2:346-356, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Mass Spectrometric Characterization of Proteins from the SARS Virus

A Preliminary Report*,S

Oleg Krokhin{ddagger},§,¶, Yan Li||,¶, Anton Andonov||, Heinz Feldmann||,**, Ramon Flick||,**, Steven Jones||, Ute Stroeher||,**, Nathalie Bastien||, Kumar V. N. Dasuri§, Keding Cheng§, J. Neil Simonsen**, Hélène Perreault{ddagger}{ddagger}, John Wilkins§, Werner Ens{ddagger},§, Frank Plummer||,§§ and Kenneth G. Standing{ddagger},§,§§

{ddagger} Physics and Astronomy, University of Manitoba, Winnipeg MB R3T 2N2, Canada
§ Manitoba Centre for Proteomics, 805 JBRC, 715 McDermot Avenue, Winnipeg MB R3E 3P4, Canada
|| National Microbiology Laboratory, 1015 Arlington Street, Winnipeg MB R3E 3R2, Canada
** Department of Medical Microbiology, University of Manitoba, 730 William Avenue, Winnipeg MB R3E OW3, Canada
{ddagger}{ddagger} Department of Chemistry, University of Manitoba, Winnipeg MB R3T 2N2, Canada

A new coronavirus has been implicated as the causative agent of severe acute respiratory syndrome (SARS). We have used convalescent sera from several SARS patients to detect proteins in the culture supernatants from cells exposed to lavage another SARS patient. The most prominent protein in the supernatant was identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as a ~46-kDa species. This was found to be a novel nucleocapsid protein that matched almost exactly one predicted by an open reading frame in the recently published nucleotide sequence of the same virus isolate (>96% coverage). A second viral protein corresponding to the predicted ~139-kDa spike glycoprotein has also been examined by MALDI-TOF MS (42% coverage). After peptide N-glycosidase F digestion, 12 glycosylation sites in this protein were confirmed. The sugars attached to four of the sites were also identified. These results suggest that the nucleocapsid protein is a major immunogen that may be useful for early diagnostics, and that the spike glycoprotein may present a particularly attractive target for prophylactic intervention in combating SARS.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 CVIHome page
L. G. Gimenez, J. Rojas, A. Rojas, J. Mendoza, and A. G. Camacho
Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody
Clin. Vaccine Immunol., February 1, 2009; 16(2): 241 - 245.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
P. Guillon, M. Clement, V. Sebille, J.-G. Rivain, C.-F. Chou, N. Ruvoen-Clouet, and J. Le Pendu
Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
Glycobiology, December 1, 2008; 18(12): 1085 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. S. Powlesland, T. Fisch, M. E. Taylor, D. F. Smith, B. Tissot, A. Dell, S. Pohlmann, and K. Drickamer
A Novel Mechanism for LSECtin Binding to Ebola Virus Surface Glycoprotein through Truncated Glycans
J. Biol. Chem., January 4, 2008; 283(1): 593 - 602.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. P. Han, M. Lohani, and M. W. Cho
Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry
J. Virol., November 1, 2007; 81(21): 12029 - 12039.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
J. Zhao, W. Wang, W. Wang, Z. Zhao, Y. Zhang, P. Lv, F. Ren, and X.-M. Gao
Comparison of Immunoglobulin G Responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS
Clin. Vaccine Immunol., July 1, 2007; 14(7): 839 - 846.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Zhao, Q. Huang, W. Wang, Y. Zhang, P. Lv, and X.-M. Gao
Identification and Characterization of Dominant Helper T-Cell Epitopes in the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus
J. Virol., June 1, 2007; 81(11): 6079 - 6088.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
C. W. Yip, C. C. Hon, F. Zeng, K. Y. C. Chow, K. H. Chan, J. S. M. Peiris, and F. C. C. Leung
Naturally Occurring Anti-Escherichia coli Protein Antibodies in the Sera of Healthy Humans Cause Analytical Interference in a Recombinant Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Severe Acute Respiratory Syndrome
Clin. Vaccine Immunol., January 1, 2007; 14(1): 99 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
B. Canas, D. Lopez-Ferrer, A. Ramos-Fernandez, E. Camafeita, and E. Calvo
Mass spectrometry technologies for proteomics
Brief Funct Genomic Proteomic, February 1, 2006; 4(4): 295 - 320.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. K. W. Law, C. Y. Cheung, H. Y. Ng, S. F. Sia, Y. O. Chan, W. Luk, J. M. Nicholls, J. S. M. Peiris, and Y. L. Lau
Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells
Blood, October 1, 2005; 106(7): 2366 - 2374.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
B. Nal, C. Chan, F. Kien, L. Siu, J. Tse, K. Chu, J. Kam, I. Staropoli, B. Crescenzo-Chaigne, N. Escriou, et al.
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E
J. Gen. Virol., May 1, 2005; 86(5): 1423 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. Yu, M. Qiu, Z. Chen, X. Ye, Y. Gao, A. Wei, X. Wang, L. Yang, J. Wang, J. Wen, et al.
Retrospective Serological Investigation of Severe Acute Respiratory Syndrome Coronavirus Antibodies in Recruits from Mainland China
Clin. Vaccine Immunol., April 1, 2005; 12(4): 552 - 554.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X. Zhong, H. Yang, Z.-F. Guo, W.-Y. F. Sin, W. Chen, J. Xu, L. Fu, J. Wu, C.-K. G. Mak, C.-S. S. Cheng, et al.
B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein
J. Virol., March 15, 2005; 79(6): 3401 - 3408.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. Qiu, J. Wang, H. Wang, Z. Chen, E. Dai, Z. Guo, X. Wang, X. Pang, B. Fan, J. Wen, et al.
Use of the COOH Portion of the Nucleocapsid Protein in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay for Specific and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus
Clin. Vaccine Immunol., March 1, 2005; 12(3): 474 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Wang, T.-h. W. Chou, P. V. Sakhatskyy, S. Huang, J. M. Lawrence, H. Cao, X. Huang, and S. Lu
Identification of Two Neutralizing Regions on the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Produced from the Mammalian Expression System
J. Virol., February 1, 2005; 79(3): 1906 - 1910.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
O.V. Krokhin, R. Craig, V. Spicer, W. Ens, K. G. Standing, R. C. Beavis, and J. A. Wilkins
An Improved Model for Prediction of Retention Times of Tryptic Peptides in Ion Pair Reversed-phase HPLC: Its Application to Protein Peptide Mapping by Off-Line HPLC-MALDI MS
Mol. Cell. Proteomics, September 1, 2004; 3(9): 908 - 919.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Simmons, J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, and P. Bates
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
PNAS, March 23, 2004; 101(12): 4240 - 4245.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
Y.-J. Tan, P.-Y. Goh, B. C. Fielding, S. Shen, C.-F. Chou, J.-L. Fu, H. N. Leong, Y. S. Leo, E. E. Ooi, A. E. Ling, et al.
Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers
Clin. Vaccine Immunol., March 1, 2004; 11(2): 362 - 371.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement